UPL prepared to acquire Arysta LifeScience for over  $4b

UPL Ltd is close to buying the farm pesticides business of investor Bill Ackman’s Platform Specialty Products Corp.—known as Arysta LifeScience—for more than $4 billion in one of the largest outbound deals by an Indian company, three people aware of the matter said.